The HSL LABS portfolio encompasses a growing collection of programs, protocols, technologies, educational resources, and recovery-focused products developed to support the post-procedural patient journey. Each initiative is designed to address specific aspects of recovery, healing, patient engagement, and outcome optimization through a structured and physician-informed framework.

The Company’s development philosophy emphasizes alignment with the biological processes that govern tissue repair and recovery. As a result, portfolio initiatives are organized around defined recovery objectives, procedural categories, patient needs, and healing phases rather than broad, generalized wellness concepts. This approach allows for greater precision in design, implementation, evaluation, and ongoing refinement.

Portfolio development is guided by contemporary scientific understanding, clinical insight, operational practicality, and continuous observational learning. Programs, protocols, technologies, and products are intended to function as complementary components within a broader recovery ecosystem that supports physicians, patients, and clinical practices throughout the recovery continuum.

As recovery science continues to evolve, the HSL LABS portfolio is designed to evolve with it. Through ongoing innovation, evaluation, and physician-informed development, the Company seeks to expand the range of solutions available to address the diverse challenges and opportunities associated with post-procedural healing, recovery management, and long-term outcome support.